does tirzepatide affect estrogen levels Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 New study links combination of

Sims-Robinson C, Bakeman A, Glasser R, Boggs J, Pacut C, Feldman EL

The primary outcome was the diagnosis of PUD, assessed in a time-dependent manner

Iron scavenging and suppression of collagen cross-linking underlie antifibrotic effects of carnosine in the heart with obesity

PMCID: PMC8373505 Pivonello C, Negri M, Patalano R, Amatrudo F, Mont T, Liccardi A, Graziadio C, Muscogiuri G, Pivonello R, Colao A (2022) The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review

A nationwide Finnish study shows that oral semaglutide was linked to meaningful metabolic improvements in everyday diabetes care, including among older adults who are often underrepresented in clinical trials